Boston Scientific Corporation vs NEPHRON: FDA Enforcement Comparison

Boston Scientific Corporation has been the subject of 285 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for NEPHRON.

Boston Scientific Corporation: 0 warning letters, 285 recalls, 0 approval records, 0 Form 483s.

NEPHRON: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Side by side

Boston Scientific Corporation — Warning letters0

NEPHRON — Warning letters0

Boston Scientific Corporation — Recalls285

NEPHRON — Recalls0

Boston Scientific Corporation — Approval records0

NEPHRON — Approval records1

Boston Scientific Corporation — Form 483s0

NEPHRON — Form 483s0

Timeline

Boston Scientific Corporation

Most recent FDA action: August 12, 2026

Full history →

NEPHRON

Most recent FDA action: June 11, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Boston Scientific Corporation vs NEPHRON: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/boston-scientific-corporation-vs-nephron

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗